Showing results (381-390 of 456) with videos related to

Sort By:
Pageof 46
The Kaohsiung Journal of Medical Sciences|November 9, 2023
Patient-centered and integrated outreach care for chronic hepatitis C patients with serious mental illness in TaiwanChung-Feng Huang, Tyng-Yuan Jang, Shun-Chieh Yu, et al.
Gastroenterology|November 28, 2017
Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBVChun-Jen Liu, Wan-Long Chuang, I-Shyan Sheen, et al.
The Kaohsiung Journal of Medical Sciences|July 12, 2025
Dynamics of Cardiometabolic Risk Factors Are Linked to the Risk of Hypertension and Diabetes in MASLDChin-I Shih, Ming-Lun Yeh, Yi-Hung Lin, et al.
Clinical Kidney Journal|December 4, 2023
Therapy as prevention toward HCV elimination in maintenance hemodialysis: a multi-center, prospective cohort studyChung-Feng Huang, Chia-Yen Dai, Chih-Wen Wang, et al.
Gut|December 11, 2020
Establishment of an outreach, grouping healthcare system to achieve microelimination of HCV for uremic patients in haemodialysis centres (ERASE-C)Ming-Lung Yu, Chung-Feng Huang, Yu-Ju Wei, et al.
American Journal of Cancer Research|February 13, 2023
Decision tree algorithm predicts hepatocellular carcinoma among chronic hepatitis C patients following viral eradicationMing-Ying Lu, Ta-Wei Liu, Po-Cheng Liang, et al.
Journal of Gastroenterology and Hepatology|April 5, 2020
Serial serologic changes of hepatitis D virus in chronic hepatitis B patients receiving nucleos(t)ides analogues therapyTyng-Yuan Jang, Yu-Ju Wei, Cheng-Ting Hsu, et al.
World Journal of Gastroenterology|February 7, 2022
Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradicationMing-Ying Lu, Ming-Lun Yeh, Ching-I Huang, et al.
Springerplus|September 3, 2016
A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3Graham R Foster, Kazuaki Chayama, Wan-Long Chuang, et al.
Gastroenterology|October 11, 2015
Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis BPatrick Marcellin, Sang Hoon Ahn, Xiaoli Ma, et al.
Pageof 46